A. Guttmacher

Genetics · 2000–2010

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom A. Guttmacher trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. David Reich

Who trusts A. Guttmacher overall

  1. Torsten Schwede

Papers from A. Guttmacher's perspective

Ordered by how strongly the researchers A. Guttmacher trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The hallmarks of cancer (RNA Biology)
  2. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
  3. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. (New England Journal of Medicine)
  4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
  5. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease (Nature)
  6. Network dynamics and cell physiology (Nature reviews. Molecular cell biology)
  7. Complement Factor H Polymorphism in Age-Related Macular Degeneration (Science)
  8. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits (Proceedings of the National Academy of Sciences of the United States of America)
  9. A genome-wide association study identifies novel risk loci for type 2 diabetes (Nature)
  10. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration (Science)

Their papers